AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Bill Tracker · Guyana

12/2021

Narcotic Drugs and Psychotropic Substances (Control) (Amendment) (No. 2) Bill 2021

Status

Pending

Amendment bill relating to the narcotics-control law. No explicit psychedelics subject identified; legislative page lists passed.

IntroducedJun 10, 2021 (done)
PassedNext step (current)
Signed— (upcoming)
Law in effect— (upcoming)

Official text

The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.

Read the full bill text

Source: parliament.gov.gy

Legislative history

No dated actions recorded yet. The progress steps above show what is confirmed.

Loading bill…